Syngene Int. - Syngene International Share Price

  • 710.00-3.05 (-0.43%)
  • Volume: 5,72,065
  • Closed
  • Last Updated On: 28 Jun, 2024, 03:58 PM IST
STOCK SCORE
ETPrime Only
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • TECHNICALS
  • COMPARE
Loading...

Syngene Int. - Syngene ...

  • 710.00-3.05 (-0.43%)
  • Volume: 5,72,065
Advertisment

Syngene Int. share price insights

View All

  • Company has spent 1.35% of its operating revenues towards interest expenses and 25.47% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)

  • Stock gave a 3 year return of 21.26% as compared to Nifty Midcap 100 which gave a return of 98.13%. (as of last trading session)

  • Stock generated 21.26% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

  • Syngene International Ltd. share price moved down by -0.43% from its previous close of Rs 713.05. Syngene International Ltd. stock last traded price is 710.00

    Share PriceValue
    Today/Current/Last710.00
    Previous Day713.05713.15

InsightsSyngene Int.

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		56.29
    EPS - TTM
    (₹)    		12.69
    MCap
    (₹ Cr.)    		28,709.90
    Sectoral MCap Rank
    		17
    PB Ratio
    (x)    		6.73
    Div Yield
    (%)    		0.18
    Face Value
    (₹)    		10.00
    Beta

    Beta

    1 Month0.40
    3 Months0.89
    6 Months0.59
    1 Year0.56
    3 Years0.69

    		0.40
    VWAP
    (₹)    		713.69
    52W H/L
    (₹)
    860.25 / 607.65

    Syngene Int. Share Price Returns

    1 Day-0.43%
    1 Week-0.41%
    1 Month3.12%
    3 Months1.06%
    1 Year-6.53%
    3 Years21.54%
    5 Years112.64%

    ET Stock ScreenersTop Score Companies

    Check whether Syngene Int. belongs to analysts' top-rated companies list?

    View Stock Screeners

    Syngene Int. News & Analysis

    View all Syngene Int. Share News & Announcements

    Syngene Int. Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Syngene Int. Share Recommendations

    Recent Recos

    HOLD

    Current

    Mean Recos by 8 Analysts

    Strong
    Sell    SellHoldBuyStrong
    Buy

    That's all for Syngene Int. recommendations. Check out other stock recos.

    Analyst Trends

    RatingsCurrent1 Week Ago1 Month Ago3 Months Ago
    Strong Buy2222
    Buy2222
    Hold---1
    Sell3222
    Strong Sell122-
    # Analysts8887
    View all Stock Recommendations

    Syngene Int. Financials

    • Income (P&L)

    • Balance Sheet

    • Cash Flow

    • Ratios

    • Insights

      • Employee & Interest Expense

        Company has spent 1.35% of its operating revenues towards interest expenses and 25.47% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)
      Quarterly | AnnualMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
      Total Income933.00882.80931.70831.701,017.20
      Total Income Growth (%)5.69-5.2512.02-18.2426.66
      Total Expenses711.10733.80768.00698.30775.90
      Total Expenses Growth (%)-3.09-4.459.98-10.0019.46
      EBIT221.90149.00163.70133.40241.30
      EBIT Growth (%)48.93-8.9822.71-44.7257.10
      Profit after Tax (PAT)188.60111.50116.5093.40178.70
      PAT Growth (%)69.15-4.2924.73-47.7362.90
      EBIT Margin (%)23.7816.8817.5716.0423.72
      Net Profit Margin (%)20.2112.6312.5011.2317.57
      Basic EPS (₹)4.702.782.902.334.46
      Quarterly | AnnualMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
      Total Income880.00820.70851.70738.701,017.20
      Total Income Growth (%)7.23-3.6415.30-27.3826.55
      Total Expenses661.10689.70712.40641.10766.10
      Total Expenses Growth (%)-4.15-3.1911.12-16.3217.72
      EBIT218.90131.00139.3097.60251.10
      EBIT Growth (%)67.10-5.9642.73-61.1364.12
      Profit after Tax (PAT)189.8099.80101.6075.30189.00
      PAT Growth (%)90.18-1.7734.93-60.1672.60
      EBIT Margin (%)24.8815.9616.3613.2124.69
      Net Profit Margin (%)21.5712.1611.9310.1918.58
      Basic EPS (₹)4.732.492.531.884.71
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue3,579.203,263.802,657.002,248.902,093.50
      Total Revenue Growth (%)9.6622.8418.157.4210.14
      Total Expenses2,947.302,670.202,141.901,814.701,647.90
      Total Expenses Growth (%)10.3824.6718.0310.1210.95
      Profit after Tax (PAT)510.00464.40395.80404.90412.10
      PAT Growth (%)9.8217.33-2.25-1.7524.28
      Operating Profit Margin (%)19.4620.0020.7021.1423.86
      Net Profit Margin (%)14.6114.5415.1918.5320.48
      Basic EPS (₹)12.7111.599.9410.1810.38
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue3,291.103,264.402,654.202,244.002,093.50
      Total Revenue Growth (%)0.8222.9918.287.1910.14
      Total Expenses2,722.702,663.502,141.801,811.601,649.10
      Total Expenses Growth (%)2.2224.3618.239.8510.94
      Profit after Tax (PAT)466.50473.00393.80403.70411.50
      PAT Growth (%)-1.3720.11-2.45-1.9024.43
      Operating Profit Margin (%)18.6620.2320.6221.1123.80
      Net Profit Margin (%)14.5614.8115.1318.5220.45
      Basic EPS (₹)11.6211.819.8910.1510.36

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets6,151.605,831.005,563.804,883.204,162.90
      Total Assets Growth (%)5.504.8013.9417.3012.40
      Total Liabilities1,893.902,213.002,266.202,061.801,987.10
      Total Liabilities Growth (%)-14.42-2.359.913.7614.52
      Total Equity4,257.703,618.003,297.602,821.402,175.80
      Total Equity Growth (%)17.689.7216.8829.6710.54
      Current Ratio (x)1.712.041.801.591.05
      Total Debt to Equity (x)0.030.160.240.270.14
      Contingent Liabilities0.00805.50664.10595.50646.00
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets5,833.905,848.005,560.804,877.504,162.00
      Total Assets Growth (%)-0.245.1614.0117.1912.42
      Total Liabilities1,642.402,229.102,268.802,059.201,987.90
      Total Liabilities Growth (%)-26.32-1.7510.183.5914.57
      Total Equity4,191.503,618.903,292.002,818.302,174.10
      Total Equity Growth (%)15.829.9316.8129.6310.52
      Current Ratio (x)1.692.111.791.591.05
      Total Debt to Equity (x)0.030.160.240.270.14
      Contingent Liabilities0.00805.50664.10595.50646.00

      All figures in Rs Cr, unless mentioned otherwise

      View Details

    • Insights

      • Decrease in Cash from Investing

        Company has used Rs 495.6 cr for investing activities which is an YoY decrease of 24.5%. (Source: Consolidated Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities1,042.10823.50580.60701.20677.10
      Net Cash used in Investing Activities-495.60-656.40-611.50-628.10-428.40
      Net Cash flow from Financing Activities-551.40-342.50-31.3058.00-225.50
      Net Cash Flow-3.80-172.30-61.50130.3027.80
      Closing Cash & Cash Equivalent85.7089.50261.80323.30193.00
      Closing Cash & Cash Equivalent Growth (%)-4.25-65.81-19.0267.5116.83
      Total Debt/ CFO (x)0.140.701.361.100.46
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities913.40838.40582.20698.00677.40
      Net Cash used in Investing Activities-383.50-688.20-611.50-628.10-428.40
      Net Cash flow from Financing Activities-536.30-340.20-31.3058.00-225.50
      Net Cash Flow-5.50-186.90-59.90127.1028.10
      Closing Cash & Cash Equivalent66.6072.10259.00318.90191.80
      Closing Cash & Cash Equivalent Growth (%)-7.63-72.16-18.7866.2717.17
      Total Debt/ CFO (x)0.160.691.361.110.46

      All figures in Rs Cr, unless mentioned otherwise

      View Details
    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)11.9712.8312.0014.3518.94
      Return on Capital Employed (%)13.5613.7512.4312.3118.30
      Return on Assets (%)8.297.967.118.299.89
      Interest Coverage Ratio (x)23.4122.2435.2226.5820.22
      Asset Turnover Ratio (x)0.580.560.500.480.51
      Price to Earnings (x)55.5651.5560.6153.7623.47
      Price to Book (x)6.636.607.257.704.44
      EV/EBITDA (x)25.1523.7828.5029.6913.85
      EBITDA Margin (%)31.6731.4832.5933.7134.76
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)11.1213.0711.9614.3218.92
      Return on Capital Employed (%)12.6214.4212.3912.2718.26
      Return on Assets (%)7.998.087.088.279.88
      Interest Coverage Ratio (x)32.7722.2435.1126.5213.84
      Asset Turnover Ratio (x)0.550.560.500.4848.33
      Price to Earnings (x)60.6150.5160.9854.0523.53
      Price to Book (x)6.736.597.277.714.44
      EV/EBITDA (x)28.7823.8128.6029.7713.88
      EBITDA Margin (%)30.1831.4732.5233.7034.70

    Financial InsightsSyngene Int.

    • Income (P&L)
    • Cash Flow

      • Employee & Interest Expense

        Company has spent 1.35% of its operating revenues towards interest expenses and 25.47% towards employee cost in the year ending 31 Mar, 2024. (Source: Consolidated Financials)

      • Decrease in Cash from Investing

        Company has used Rs 495.6 cr for investing activities which is an YoY decrease of 24.5%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Syngene Int. Share Price Forecast

    • PRICE

    • REVENUE

    • EARNINGS

    • Get multiple analysts’ prediction on Syngene Int.

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    • Get multiple analysts’ prediction on Syngene Int.

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    • Get multiple analysts’ prediction on Syngene Int.

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    Syngene Int. Peer Comparison

    • Syngene Int. Stock Performance

    • Ratio Performance

      • CHART
      • TABLE

      Insights

      • Stock Returns vs Nifty Midcap 100

        Stock gave a 3 year return of 21.26% as compared to Nifty Midcap 100 which gave a return of 98.13%. (as of last trading session)

      • Stock Returns vs Nifty Pharma

        Stock generated 21.26% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Insights

          • Stock Returns vs Nifty Midcap 100

            Stock gave a 3 year return of 21.26% as compared to Nifty Midcap 100 which gave a return of 98.13%. (as of last trading session)

          • Stock Returns vs Nifty Pharma

            Stock generated 21.26% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

          Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Syngene Int.56.296.7411.9713.568.2916.5719.4614.6112.711.710.030.14
          Glenmark Pharma-21.414.44-19.1317.01-10.454.7512.30-12.13-53.221.280.13-3.73
          Gland Pharma38.763.438.8512.507.2417.3020.4513.6346.904.040.040.32
          Ajanta Pharma35.668.1622.8729.9517.5913.6226.6319.3964.823.050.000.00
          Ipca Labs51.043.628.6412.444.9312.4814.126.8621.572.350.221.47
          Add More
          Annual Ratios (%)

          Choose from Peers

          • J B Chemicals
          • Aarti Inds
          • Laurus Labs
          • Piramal Pharma
          • Natco Pharma

          Choose from Stocks

            See All Parameters

          Peers InsightsSyngene Int.

          • Stock Returns vs Nifty Midcap 100

            Stock gave a 3 year return of 21.26% as compared to Nifty Midcap 100 which gave a return of 98.13%. (as of last trading session)

          • Stock Returns vs Nifty Pharma

            Stock generated 21.26% return as compared to Nifty Pharma which gave investors 38.67% return over 3 year time period. (as of last trading session)

          Do you find these insights useful?

          • hate it

          • meh

          • love it

          Syngene Int. Shareholding Pattern

          • QOQ Change

          • Total Shareholdings

          • Loading...
            Showing Syngene Int. Shareholding as on 31 Mar 2024
            Category31 Mar 202431 Dec 202330 Sep 202330 Jun 2023
            Promoters54.7954.7954.7954.80
            Pledge0.000.000.000.00
            FII20.9121.2023.5523.18
            DII15.7814.6211.7011.20
            Mutual Funds12.5911.939.098.58
            Others8.519.399.9510.82
          • Showing Shareholding as on 31 Mar 2024
            CategoryNo. of SharesPercentage% Change QoQ
            Promoters22,02,83,69754.79 %0.00
            Pledge00.00 %0.00
            FII8,41,15,88420.91 %-0.28
            DII6,34,09,33915.78 %1.15
            MF5,06,07,03512.59 %0.66
            Others3,42,06,0808.51 %-0.87

          MF Ownership

          MF Ownership as on 31 May 2024

          View all Mutual Fund Schemes

          Top Searches:

          Syngene Int. News Syngene Int. Quarterly Results Syngene Int. Dividend Syngene Int. Q1 ResultsSyngene Int. Q2 ResultsSyngene Int. Q3 ResultsSyngene Int. Q4 Results

          Corporate Actions

          • Syngene Int. Board Meeting/AGM

          • Syngene Int. Dividends

          • Others
          • Meeting DateAnnounced onPurposeDetails
            Jul 24, 2024Jun 28, 2024Board MeetingQuarterly Results
            Apr 24, 2024Apr 01, 2024Board MeetingAudited Results & Final Dividend
            Jan 25, 2024Dec 26, 2023Board MeetingQuarterly Results
            Oct 17, 2023Oct 06, 2023Board MeetingQuarterly Results
            Jul 26, 2023Jul 13, 2023Board MeetingQuarterly Results
          • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
            Final12%1.25Jun 28, 2024Apr 24, 2024
            Final5%0.5Jun 30, 2023Apr 26, 2023
            Special5%0.5Jun 30, 2022Apr 28, 2022
            Final5%0.5Jun 30, 2022Apr 27, 2022
            Final5%0.5Jul 16, 2019Apr 24, 2019
          • All TypesEx-DateRecord DateAnnounced onDetails
            BonusJun 11, 2019Jun 12, 2019Apr 24, 2019Bonus Ratio: 1 share(s) for every 1 shares held

          About Syngene Int.

          Syngene International Ltd., incorporated in the year 1993, is a Mid Cap company (having a market cap of Rs 28,543.07 Crore) operating in Pharmaceuticals sector. Syngene International Ltd. key Products/Revenue Segments include Contract Research & Contract Manufacturing (CRAMS), Other Operating Revenue and Scrap for the year ending 31-Mar-2023. Show More

          • Executives

          • Auditors

          • KM

            Kiran Mazumdar Shaw

            Non Executive Chairman
            JH

            Jonathan Hunt

            Managing Director & CEO
            CR

            Catherine Rosenberg

            Non Executive Director
            CD

            Carl Decicco

            Independent Director
            Show More
          • B S R & Co. LLP

          Industry

          Pharma - Indian

          Key Indices Listed on

          Nifty Midcap 100, Nifty 200, Nifty 500, + 20 more

          Address

          Biocon SEZ, Biocon Park,Plot No. 2 & 3,Bommasandra Industrial Area,Bengaluru, Karnataka - 560099

          Contact

          [email protected]

          http://www.syngeneintl.com

          More Details

          Trending in Markets

          DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

          DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

          By using this site, you agree to the Terms of Service and Privacy Policy.

          Business News›Markets›Stocks›Stock Price Quotes›Syngene Int. Share Price
          The Economic Times